Home >

Welcome to ASCO Connection Discussion

The ASCO Connection Discussion forum is a space for oncology professionals and others with an interest in cancer care to ask and answer questions about every aspect of the field, from professional development advice to clinical conundrums. Everyone is welcome to participate: to ask a question or leave a response, first log in with your ASCO username and password. Please read the Discussion and Commenting Guidelines before you post a question or response. Contact our staff by email for assistance with the Discussion forum.

Filter by All Topics
Jade Parker
May 31, 2017 10:24 AM
Oncology Central will be hosting a free CME-accredited online symposium next month. Save your space for free: https://conferences.oncology-central.com/?partnerref=ASCOf  
Register for free and to listen to talks from renowned...
Molecular Oncology Tumor Board
ASCO University
May 10, 2017 8:23 AM
Read more to answer the following questions: 1) Is the location and morphology of this tumor significant clinically? 2) Prior to NGS what additional testing could have been performed? 3) Is one test for hereditary colon cancer better than the other? 4) What is the role of genetic counseling for...
Virginia D. Anderson
May 05, 2017 12:55 PM
The National Coalition for Cancer Survivorship (NCCS) is now accepting submissions for its Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care. The award will recognize exceptional providers whose focus on quality care has touched all aspects of cancer care, including respecting...
ASCO Connection
May 04, 2017 4:11 PM
If you read our Exclusive Journal Coverage story on physician-patient communication in Sri Lanka, you know that norms around what information is given to (or kept from) the patient and their...
ASCO Connection
May 04, 2017 4:08 PM
This question was posed by an attendee at the 2017 Genitourinary Cancers Symposium. What do you think?
Should men with DNA break repair mutations (BRCA1, BRCA2, ATM, etc) found on a genetic test, but who otherwise have low-risk disease, be considered for surveillance? What is the data?